3D Printed Drugs Market: Current Analysis and Forecast (2020-2027)

$3500$6860

Emphasis on Technology (Inkjet Printing, Fused Deposition Modelling, Stereolithography, Others), Application (Orthopaedic, Neurology, Hearing & Audibility Aid, Medical Implants, Dental, Others), Drug Form (Tablet, Capsules, Multi Drug Implants, Nano Particles, Solutions, Nano Suspension, Encapsulated within a Polymer, Implant), Drugs (Spritam, Others), End-Users (Hospitals, Clinics, Research Laboratories), and Region/Country

Pages:

168

Table:

46

Figure:

134

Report ID:

UMHE21198

Geography:

Clear
  Get a Free Sample
SKU: UMHE21198 Category:
Report Description
Table of content
Research Methodology

Report Description

The global 3D printed drugs market is witnessing an uptick on account of the government’s investment in the 3D printing technology, raising venture capital for 3D printing startups, and the investment by the pharma companies in 3D printing technology. In a study, it was found that around 63% of the pharma companies are thinking of investing in 3D printing technology and the number of professionals using 3D printing technology was 3 times higher than that of 3 years ago which was in 2017. The Venture capital funding for 3D printing is also one of the most prominent reasons for market growth. Furthermore, the state of Lower Austria and the Austrian federal government together announced two funding packages in 2020 which will support investments in advanced digital technologies, including 3D printing.

Moreover, the surging prevalence of chronic disease and the rising number of patients globally generating the demand for soluble drugs, due to which the demand for personalized 3D printed medicine is emerging. In a study, it was found that Dysphagia affects approximately 9 million adults per year in the United States and is especially prevalent among the elderly. Characteristically, 50-75% of stroke patients and 60-70% of patients who undergo radiation therapy for head and neck cancer have dysphagia. The government across countries is investing more in healthcare and more emphasis on 3D printing technology for quick production owing to the surging need globally. As per OCED, the government in the United States spend USD 8,032.6 USD per capita in 2015 that increased to USD 9,386.5 USD per capita in 2019 same way in the U.K the government spent 3,043.6 USD per capita in 2015 that increased to USD 3619.5 USD per capita in 2019.

Also, surging government’s emphasis on personalized medicine and the rising end-user’s awareness about the medicine as per individual’s need coupled with the benefits such as high dose in single tablet, swallowable, and different form of drugs is generating the demand for the 3D printed drugs so, the market is promulgating.

3D Printed Drug Formulation Technologies

 

The global 3D Printed Drugs market is highly fragmented. The availability of numerous global and local players across regions makes the industry highly competitive. The key players with a considerable market share in the industry are GlaxoSmithKline plc., Aprecia Pharmaceuticals, LLC., AstraZeneca, FabRx Ltd, Merck KGaA, Hewlett Packard Caribe, Cycle Pharmaceuticals, Tvasta, etc. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst technology, inkjet printing segment holds the major share”

Based on product type, the market is fragmented into inkjet printing, fused deposition modeling, stereolithography, and others. The inkjet printing segment dominated the market with a share of 42.2% in 2019 and is expected to maintain its dominance during the forecast period on account of the benefits such as low cost, programmability, high resolution, high throughput, high speed, and biocompatibility of these printers and the launch of new products by the key players in the industry.

“Amongst applications, neurology is expected to dominate the market during the analyzed period”

Based on the applications market is segmented into Orthopedic, Neurology, Hearing & Audibility Aid, Medical Implants, Dental, and others. In 2019, the neurology segment grabbed the major market share and accounted for 35.1% of the market revenue share.  The surging prevalence of the neurological disorder is leading to the growing share of this segment. In a study, it was found that Neurological disorders are the number one cause of disability globally and around 1 billion people throughout the world are affected by some type of neurological disease. Moreover, the orthopedic segment is expected to grow with a CAGR of more than 15.9% during the forecast period of 2021-27.

“Amongst drug form, the tablet is expected to dominate the market during the analyzed period”

Based on the drug form, the market is segmented into the tablet, capsules, multidrug implants, nanoparticles, solutions, nanosuspension, encapsulated within a polymer, and others. In 2019, the tablet segment grabbed the major market share and accounted for 29.8% of the market revenue share.  The properties of tablets such as longer shelf life, variety of forms. Also, it accommodates a higher dose of an active ingredient than a capsule. Moreover, the capsule segment is expected to grow with a CAGR of more than 15.8% during the forecast period of 2021-27.

“North America represents one of the largest markets of the 3D Printed Drugs market”

For a better understanding of the market dynamics of the 3D Printed Drugs market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of APAC) and Rest of the World has been conducted. North America dominated the market and generated revenue of US$ 306.8 million in 2019 owing to the escalating healthcare IT investment in the countries such as the U.S and Canada. Moreover, the presence of well-established players in additive manufacturing makes the region dominant across the globe.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The 3D Printed Drugs market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

  1.1Market Definitions 
  1.2Objective of the Study
  1.3Limitation 
  1.4Stake Holders 
  1.5Currency Used in Report
  1.6Scope of the Global 3D Printed Drugs Market Study

 

  2.1Research Methodology for the Global 3D Printed Drugs Market
   2.1.1Main Objective of the Global 3D Printed Drugs Market

 

  7.1Inkjet Printing 
  7.2Fused Deposition Modelling
  7.3Stereolithography 
  7.4Others

 

  8.1Orthopaedic 
  8.2Neurology 
  8.3Hearing & Audibility Aid
  8.4Medical Implants 
  8.5Dental  
  8.6Others

 

  9.1Tablets  
  9.2Capsules  
  9.3Multi Drug Implants 
  9.4Nano Particles 
  9.5Solutions  
  9.6Nano Suspension 
  9.7Encapsulated within a Polymer
  9.8Implant

 

  10.1Spritam  
  10.2Others

 

  11.1Hospitals  
  11.2Clinics  
  11.3Research Laboratories
  12.1North America 3D Printed Drugs Market 
   12.1.1US 
   12.1.2Canada 
   12.1.3Rest of North America
  12.2Europe 3D Printed Drugs Market 
   12.2.1United Kingdom
   12.2.2France 
   12.2.3Germany 
   12.2.4Spain 
   12.2.5Italy 
   12.2.6Rest of Europe
  12.3Asia Pacific 3D Printed Drugs Market
   12.3.1China 
   12.3.2India 
   12.3.3Japan 
   12.3.4Australia 
   12.3.5South Korea
   12.3.6Rest of Asia Pacific
  12.4Rest of the World 3D Printed Drugs Market 

 

  13.1Market Drivers 
  13.2Market Challenges 
  13.3Impact Analysis
  15.1Demand Side Analysis
  15.2Supply Side Analysis
   15.2.1Top Product Launches
   15.2.2Top Business Partnerships
   15.2.3Top Merger & Acquisitions
   15.2.4Top Business Expansions and Investments
  19.1Porter’s Five forces analysis
   19.1.1Bargaining power of Supplier
   19.1.2Bargaining power of Buyer
   19.1.3Industry Rivalry
   19.1.4Availability of Substitute
   19.1.5Threat of new Entrants
  19.2Competitive Landscape
   19.2.1Company Shares, By Revenue
  19.3Competition Matrix 
   19.3.1Product/Service Portfolio
   19.3.2Target Markets
   19.3.3Target End Users
   19.3.4Research and Developments    
   19.3.5Strategic Alliances
  20.1Aprecia Pharmaceuticals, LLC
   20.1.1Key Facts 
   20.1.2Business Description
   20.1.3Key Product/Services Offerings
   20.1.4Growth Strategy
   20.1.5SWOT Analysis
   20.1.6Key Financials
    20.1.6.1Revenue Split
    20.1.6.2Financial Overview of Koninklijke Philips NV
   20.1.7Recent Developments
    20.1.7.1Product Launch
    20.1.7.2Partnerships
    20.1.7.3Business Expansion and Investments
    20.1.7.4Merger and Acquisition
  20.2GlaxoSmithKline plc
  20.3AstraZeneca 
  20.4FabRx Ltd  
  20.5Hewlett Packard Caribe
  20.6Merck KGaA 
  20.7Cycle Pharmaceuticals
  20.8Tvasta

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the global 3D printed drugs to the market were the three major steps undertaken to create and analyze the adoption of 3D printed drugs across various healthcare verticals in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the 3D printed drugs market. Post assumption and validation of market numbers through primary interviews, we employed a top-down approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the 3D printed drugs through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the 3D printed drugs market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as type and subtypes. Further country-level analyses were conducted to evaluate the overall adoption of 3D Printed Drugs in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of 3D printed drugs. Further, we conducted factor analysis using dependent and independent variables such as the growth of the healthcare industry, surging prevalence of diseases, Investments, etc. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the 3D printed drugs industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the 3D printed drugs market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the adoption rate of 3D printed drugs across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the 3D printed drugs market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the 3D printed drugs market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type and their type of the 3D printed drugs market.

The main objective of the 3D Printed Drugs Market Study

The current & future market trends of 3D printed drugs were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of 3D printed drugs in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of type and their subtypes
  • Define and analysis of the regulatory framework for the 3D printed drugs industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the 3D printed drugs market for the major region
  • Major regions studied in the report include North America (the U.S and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India, Australia, and South Korea), and the Rest of the World
  • Company profiles of the 3D printed drugs market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry